Patient 1, who was diagnosed with Ph-like ALL, with the BCR-JAK2 fusion gene and IKZF1 deletion (Table 1), experienced MRD-negative CR with a molecular remission on day 28 after T-cell infusion. Here, JAK2 is linked to acute lymphoblastic leukemia.